Skip to main content

Cryptosporidiosis

3
Pipeline Programs
2
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
4 programs
1
1
NitazoxanidePhase 21 trial
LetrazurilPhase 11 trial
Transmission and the Respiratory Tract in CryptosporidiosisN/A1 trial
SpiramycinPHASE_12 trials
Active Trials
NCT00507871Completed480Est. Jan 2009
NCT00000980Completed25
NCT00004317Recruiting600Est. Dec 2030
+2 more trials
Sandoz
SandozAustria - Kundl
1 program
1
Cryptosporidium parvum oocystsPhase 21 trial
Active Trials
NCT07249463Recruiting96Est. Mar 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Allergy TherapeuticsSpiramycin
Allergy TherapeuticsNitazoxanide
SandozCryptosporidium parvum oocysts
Allergy TherapeuticsTransmission and the Respiratory Tract in Cryptosporidiosis

Clinical Trials (6)

Total enrollment: 1,293 patients across 6 trials

NCT00004317Allergy TherapeuticsSpiramycin

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Start: Jul 2000Est. completion: Dec 2030600 patients
Phase 4Recruiting
NCT00001081Allergy TherapeuticsNitazoxanide

A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

Est. completion: Sep 199860 patients
Phase 2Completed
NCT07249463SandozCryptosporidium parvum oocysts

Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults

Start: Dec 2025Est. completion: Mar 202796 patients
Phase 2Recruiting
NCT00000980Allergy TherapeuticsSpiramycin

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

25 patients
Phase 1Completed
NCT00001018Allergy TherapeuticsLetrazuril

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

32 patients
Phase 1Completed
NCT00507871Allergy TherapeuticsTransmission and the Respiratory Tract in Cryptosporidiosis

Transmission and the Respiratory Tract in Cryptosporidiosis

Start: Oct 2007Est. completion: Jan 2009480 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,293 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.